Please join the Engelberg Center for Health Care Reform in an upcoming webinar, “Findings from a Mini-Sentinel Assessment: Influenza Vaccines and Risk of Febrile Seizures,” on Monday, July 21, 2014, from 1:00 PM to 2:00 PM EDT.
Mini-Sentinel investigators have recently completed an assessment that examined a possible association between use of certain trivalent inactivated influenza vaccines and febrile seizures in children. This protocol-based assessment compared the relative risk of febrile seizures in children receiving influenza vaccines, in addition to the effect of particular modifying factors on the relative risk. While not intended to provide a definitive conclusion on the association, the results will help to interpret the larger context of what is known about the vaccines from various sources. The assessment also enabled Mini-Sentinel investigators to build general strategies to assess suspected associations of selected medical products and adverse events.
Dr. Michael Nguyen, Deputy Director, Division of Epidemiology, in the Center for Biologics Evaluation and Research at the U.S. Food and Drug Administration, will provide a brief description of the rationale for conducting this study. Dr. Alison Kawai, an epidemiologist at Harvard Pilgrim Health Care Institute and Harvard Medical School, will present an overview of findings from the medical product assessment.
Welcome and Introduction
Greg Daniel, Managing Director and Fellow, Engelberg Center for Health Care Reform, Brookings Institution
FDA Opening Remarks
Michael Nguyen, Deputy Director, Division of Epidemiology, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
Overview of Results from Mini-Sentinel Medical Product Assessment
Alison Kawai, Epidemiologist, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
Roundtable Discussion and Questions
Note: This roundtable will have an online webinar component to facilitate more interactive presentations and discussion. However, participation by teleconference only is also available. Details are below.